McGill.CA / Surgical and Interventional Sciences / Programs / Master Programs

MSc-Non Thesis in Experimental Surgery - Oncology

The Gerald Bronfman Department of Oncology has partnered with the Division of Surgical and Interventional Sciences to provide students the opportunity to use the Graduate Diploma in Oncology as a springboard for a master’s non-thesis degree in Experimental Surgery. Students who will be completing the Graduate Diploma in Oncology can choose Option 1 or Option 2 (below).

If Option 1 (stackable master’s non-thesis) is chosen, students will complete the Graduate Diploma in Oncology and then register for the Graduate Certificate in Surgical Innovation.

If Option 2 (MSc non-thesis in Experimental Surgery - Oncology concentration) is chosen, full-time students will be able to apply for the MSc program while completing their final term in the Graduate Diploma in Oncology. Students who are part-time will be able to apply once they have completed at least 21 credits of the Graduate Diploma in Oncology. If accepted into this MSc program, it will be conditional upon successful completion of the Diploma’s 30 credits of coursework. These credits will then be transferred to the master's degree and students will take an additional 15 credits of courses required by Surgical and Interventional Sciences as shown below.

Students who completed the Graduate Diploma in Oncology in previous years and were therefore officially granted the Diploma, can only choose the stackable route (Option 1).

Option 1: Stackable Master's Non-thesis (45 credits)


Option 2: Master's Non-thesis in Experimental Surgery, Oncology concentration (45 credits)

  • Graduate Diploma in Oncology (30 credits)
    Note: In this case the student will not be granted the official Diploma, as the 30-credits will be transferred to the MSc program requirements.
  • EXSU 500 Artificial Intelligence in Medicine (3 credits)
  • EXSU 602 Knowledge Management 2 (3 credits)
  • EXSU 623 Surgery Research Project 2 (6 credits)


3 credits selected from:

  • BMDE 653 Patents in Biomedical Engineering. (3 cr.)
  • BMDE 654 Biomedical Regulatory Affairs-Medical Devices (3 cr.)
  • BMDE 655 Biomedical Clinical Trials-Medical Devices (3 cr.)
  • EDPE 637 Issues in Health Professions Education (3 cr.)
  • EDPE 687 Qualitative Methods in Educational Psychology (3 cr.)
  • EDPH 689 Teaching and Learning Higher Education (3 cr.)
  • EPIB 521 Regression Analysis for Health Sciences (3 cr.)
  • EPIB 681 Global Health: Epidemiological Research (3 cr.)
  • EXMD 609 Cellular Methods in Medical Research (3 cr.)
  • EXMD 610 Molecular Methods in Medical Research (3 cr.)
  • EXSU 505 Trends in Precision Oncology (3 cr.)
  • EXSU 601 Knowledge Management 1 (3 cr.)
  • EXSU 603 Surgical Education Foundations (3 cr.)
  • EXSU 605 Biomedical Research Innovation (3 cr.)
  • EXSU 620 Surgical Innovation 1 (3 cr.)
  • EXSU 684 Signal Transduction (3 cr.)

 

The two MSc programs have been approved to start in Fall 2022. Any questions about registration for either of the programs should be addressed to Surgical and Interventional Sciences.

 

CONTACT

Gerald Bronfman Department of Oncology
5100 de Maisonneuve Blvd. West, Suite 720
Montreal, Quebec, Canada H4A 3T2

Tel: 514-398-4596
Email: admin.onc [at] mcgill.ca

Further details can be found at:
https://www.mcgill.ca/oncology/education-training/graduate-diploma-oncology

Or

Micha Huynh
Administrative and Student Affairs Coordinator
Division of Surgical and Interventional Sciences
Montreal General Hospital, Room A7.117
1650 Cedar Avenue, Montreal, Quebec H3G 1A4 Canada

Tel: 514-934-1934, Ex. 45578
Email: gradstudies2.surgery [at] mcgill.ca

 

 

Back to top